Home
About
FAQ
History (1)
Re: Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Re: Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma.
Atala A. Re: Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma. J Urol. 2012 Jun; 187(6):2276-7.
View in:
PubMed
authors with profiles
Anthony Atala MD